467 related articles for article (PubMed ID: 29103089)
1. HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
Vitali C; Khetarpal SA; Rader DJ
Curr Cardiol Rep; 2017 Nov; 19(12):132. PubMed ID: 29103089
[TBL] [Abstract][Full Text] [Related]
2. Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention.
Orho-Melander M
J Intern Med; 2015 Nov; 278(5):433-46. PubMed ID: 26477595
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Association Study Identifies a Functional
León-Mimila P; Villamil-Ramírez H; Macías-Kauffer LR; Jacobo-Albavera L; López-Contreras BE; Posadas-Sánchez R; Posadas-Romero C; Romero-Hidalgo S; Morán-Ramos S; Domínguez-Pérez M; Olivares-Arevalo M; López-Montoya P; Nieto-Guerra R; Acuña-Alonzo V; Macín-Pérez G; Barquera-Lozano R; Del-Río-Navarro BE; González-González I; Campos-Pérez F; Gómez-Pérez F; Valdés VJ; Sampieri A; Reyes-García JG; Carrasco-Portugal MDC; Flores-Murrieta FJ; Aguilar-Salinas CA; Vargas-Alarcón G; Shih D; Meikle PJ; Calkin AC; Drew BG; Vaca L; Lusis AJ; Huertas-Vazquez A; Villarreal-Molina T; Canizales-Quinteros S
Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2494-2508. PubMed ID: 34233476
[TBL] [Abstract][Full Text] [Related]
4. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in Humans.
Khetarpal SA; Babb PL; Zhao W; Hancock-Cerutti WF; Brown CD; Rader DJ; Voight BF
Circ Genom Precis Med; 2018 Jul; 11(7):e002070. PubMed ID: 29987113
[TBL] [Abstract][Full Text] [Related]
6. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.
Burgess S; Harshfield E
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):124-30. PubMed ID: 26910273
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
Peloso GM; Demissie S; Collins D; Mirel DB; Gabriel SB; Cupples LA; Robins SJ; Schaefer EJ; Brousseau ME
J Lipid Res; 2010 Dec; 51(12):3524-32. PubMed ID: 20855565
[TBL] [Abstract][Full Text] [Related]
8. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol.
Khetarpal SA; Edmondson AC; Raghavan A; Neeli H; Jin W; Badellino KO; Demissie S; Manning AK; DerOhannessian SL; Wolfe ML; Cupples LA; Li M; Kathiresan S; Rader DJ
PLoS Genet; 2011 Dec; 7(12):e1002393. PubMed ID: 22174694
[TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
[TBL] [Abstract][Full Text] [Related]
10. Genetics of cholesterol efflux.
Iatan I; Palmyre A; Alrasheed S; Ruel I; Genest J
Curr Atheroscler Rep; 2012 Jun; 14(3):235-46. PubMed ID: 22528521
[TBL] [Abstract][Full Text] [Related]
11. Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol.
Edmondson AC; Braund PS; Stylianou IM; Khera AV; Nelson CP; Wolfe ML; Derohannessian SL; Keating BJ; Qu L; He J; Tobin MD; Tomaszewski M; Baumert J; Klopp N; Döring A; Thorand B; Li M; Reilly MP; Koenig W; Samani NJ; Rader DJ
Circ Cardiovasc Genet; 2011 Apr; 4(2):145-55. PubMed ID: 21303902
[TBL] [Abstract][Full Text] [Related]
12. Variants at the APOE /C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High-Density Lipoprotein Cholesterol.
Low-Kam C; Rhainds D; Lo KS; Barhdadi A; Boulé M; Alem S; Pedneault-Gagnon V; Rhéaume E; Dubé MP; Busseuil D; Hegele RA; Lettre G; Tardif JC
J Am Heart Assoc; 2018 Aug; 7(16):e009545. PubMed ID: 30369316
[TBL] [Abstract][Full Text] [Related]
13. Is High-Density Lipoprotein Cholesterol Causally Related to Kidney Function? Evidence From Genetic Epidemiological Studies.
Coassin S; Friedel S; Köttgen A; Lamina C; Kronenberg F
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2252-2258. PubMed ID: 27687604
[TBL] [Abstract][Full Text] [Related]
14. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
[TBL] [Abstract][Full Text] [Related]
15. Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids.
Beaney KE; Cooper JA; McLachlan S; Wannamethee SG; Jefferis BJ; Whincup P; Ben-Shlomo Y; Price JF; Kumari M; Wong A; Ong K; Hardy R; Kuh D; Kivimaki M; Kangas AJ; Soininen P; Ala-Korpela M; Drenos F; Humphries SE;
Cardiovasc Diabetol; 2016 Aug; 15(1):115. PubMed ID: 27549350
[TBL] [Abstract][Full Text] [Related]
16. Genetic and observational evidence: No independent role for cholesterol efflux over static high-density lipoprotein concentration measures in coronary heart disease risk assessment.
Kuusisto S; Karjalainen MK; Tillin T; Kangas AJ; Holmes MV; Kähönen M; Lehtimäki T; Viikari J; Perola M; Chaturvedi N; Salomaa V; Raitakari OT; Järvelin MR; Kettunen J; Ala-Korpela M
J Intern Med; 2022 Jul; 292(1):146-153. PubMed ID: 35289444
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
Tailleux A; Duriez P; Fruchart JC; Clavey V
Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
[TBL] [Abstract][Full Text] [Related]
18. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
19. Low HDL concentration in rs2048327-G carriers can predispose men to develop coronary heart disease: Tehran Cardiometabolic genetic study (TCGS).
Najd Hassan Bonab L; Moazzam-Jazi M; Miri Moosavi RS; Fallah MS; Lanjanian H; Masjoudi S; Daneshpour MS
Gene; 2021 Apr; 778():145485. PubMed ID: 33581269
[TBL] [Abstract][Full Text] [Related]
20. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
Boes E; Coassin S; Kollerits B; Heid IM; Kronenberg F
Exp Gerontol; 2009 Mar; 44(3):136-60. PubMed ID: 19041386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]